A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The ...

Oral TYK2 inhibitor deucravacitinib receives FDA approval for active psoriatic arthritis based on significantly improved ...

Patients with axial spondyloarthritis and psoriatic arthritis face an elevated risk for all-cause mortality compared with the ...

McKenzie Law Firm announces Amari Bailey as the 2025 Teen Drinking and Driving Prevention PSA Scholarship winner, ...

Delivering the keynote address, Prof. Ajay Sood, Principal Scientific Advisor (PSA) to the Government of India, underscored the urgency of breaking silos across health systems.

The FDA will review the supplemental Biologics License Application for tildrakizumab for the treatment of adults with active PsA.

A negative PSMA-PET/CT at BCR identified a favorable-risk group with 2- and 5-year PFS of 78.3% and 62.4%, respectively, despite no visible lesions. Whole-pelvis radiotherapy improved PFS in locally ...

Maintaining a healthy weight plays an important role in managing an inflammatory condition like psoriatic arthritis. Overweight and obesity have been linked to an increased risk of psoriatic arthritis ...

Researchers have discovered immune cells that escape inflamed skin, travel through the blood, and help spark psoriatic arthritis once they reach vulnerable joints. Credit Shutterstock Scientists have ...